货号：UP264278495
| 产品信息 | |
| 产品名称： | FMK |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 821794-92-7 |
| 分子式： | C18H19FN4O2 |
| 分子量： | 342.37 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP264278495) |
| 沸点： | - |
| 储存： | (UP264278495) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
Bortezomib
UP959825699179324-69-7
LECIRELIN
UP65359667161012-19-9
4,4,4,4-(Porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid)
UP991351831914609-54-2
YM-155 hydrochloride
UP263151238355406-09-6
Nafarelin
UP77098863676932-56-4
Pifithrin-α hydrobromide
UP58121045763208-82-2
Kevetrin hydrochloride
UP52273339366592-89-0
Resiquimod
UP458050387144875-48-9
Necrostatin 1
UP4191557134311-88-0
Boric anhydride
UP34112545591303-86-2
GSK481
UP3600794531622849-58-4
Elagolix
UP789444331834153-87-6
6-Cyano-9-(diethylamino)-5H-benzo[a]phenoxazin-5-one
UP7493105643128119-95-9
Triptorelin
UP75587421057773-63-4
TC-DAPK 6
UP669043601315694-89-4
Neratinib Maleate
UP200720262915942-22-2
Pomalidomide
UP70220021219171-19-8
Oprozomib
UP242482345935888-69-0
LJH685
UP7665361461627710-50-2
MK-3697
UP1412659781224846-01-8
Mutated EGFR-IN-1
UP1200422071421372-66-8
AKT inhibitor VIII
UP998464122612847-09-3
Cloprostenol sodium salt
UP943997077555028-72-3
Dehydroglyasperin C
UP549406836199331-35-6
Lenalidomide hydrochloride
UP2933778241243329-97-6
BIX-02565
UP4639477991311367-27-7
BI-D1870
UP683157370501437-28-1
LY2584702
UP1870046981082949-67-4
Trimebutine
UP94753881139133-31-8
LY2584702 Hydrochloride
UP1960674401082948-81-9
AC480
UP309988617714971-09-2
(2S,5R,6R)-6-(3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]
UP251101961847-24-1
LJI308
UP2304532831627709-94-7
Carfilzomib
UP896392163868540-17-4
SL0101
UP72975987777307-50-7
FMK
UP264278495821794-92-7